Canvas Wealth Advisors LLC reduced its holdings in Globe Life Inc. (NYSE:GL – Free Report) by 21.6% during the second quarter, Holdings Channel reports. The firm owned 5,086 shares of the company’s stock after selling 1,400 shares during the period. Canvas Wealth Advisors LLC’s holdings in Globe Life were worth $682,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Global Assets Advisory LLC bought a new stake in shares of Globe Life in the 2nd quarter worth approximately $25,000. AdvisorNet Financial Inc raised its holdings in shares of Globe Life by 60.0% in the 2nd quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock worth $28,000 after purchasing an additional 84 shares in the last quarter. TD Private Client Wealth LLC bought a new stake in shares of Globe Life in the 2nd quarter worth approximately $39,000. SouthState Corp bought a new stake in shares of Globe Life in the 1st quarter worth approximately $43,000. Finally, Ransom Advisory Ltd bought a new stake in shares of Globe Life in the 1st quarter worth approximately $50,000. 81.61% of the stock is currently owned by institutional investors.
Globe Life Stock Performance
Shares of GL opened at $134.78 on Monday. The company’s 50 day moving average price is $139.85 and its 200 day moving average price is $128.96. Globe Life Inc. has a 52 week low of $100.27 and a 52 week high of $147.83. The company has a market capitalization of $10.92 billion, a PE ratio of 10.77 and a beta of 0.55. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.06 and a current ratio of 0.06.
Globe Life Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be given a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. Globe Life’s payout ratio is presently 8.63%.
Wall Street Analyst Weigh In
A number of research firms recently commented on GL. Weiss Ratings reiterated a “buy (b-)” rating on shares of Globe Life in a report on Wednesday, October 8th. Truist Financial initiated coverage on shares of Globe Life in a report on Tuesday, July 15th. They set a “buy” rating and a $150.00 price target on the stock. Keefe, Bruyette & Woods boosted their price target on shares of Globe Life from $145.00 to $155.00 and gave the company an “outperform” rating in a report on Monday, July 28th. Wells Fargo & Company boosted their price target on shares of Globe Life from $150.00 to $172.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Globe Life from $145.00 to $160.00 and gave the company an “overweight” rating in a report on Tuesday, July 8th. Eight equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $152.11.
Get Our Latest Report on Globe Life
Insider Activity at Globe Life
In other Globe Life news, CEO James Matthew Darden sold 33,270 shares of the business’s stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $135.59, for a total value of $4,511,079.30. Following the completion of the sale, the chief executive officer directly owned 49,842 shares of the company’s stock, valued at $6,758,076.78. The trade was a 40.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Frank M. Svoboda sold 12,500 shares of the business’s stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $141.38, for a total transaction of $1,767,250.00. Following the completion of the sale, the chief executive officer directly owned 32,747 shares of the company’s stock, valued at $4,629,770.86. This represents a 27.63% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 84,722 shares of company stock valued at $11,733,793. Company insiders own 1.97% of the company’s stock.
Globe Life Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Further Reading
- Five stocks we like better than Globe Life
- Large Cap Stock Definition and How to Invest
- JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?
- How to start investing in penny stocks
- Snap-on Incorporated: Snap It Up Quick, New Highs Will Come Soon
- How to trade penny stocks: A step-by-step guide
- As Global Renewables Surpass Coal, This ETF Offers Smart Exposure
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.